Dudediligence.

Jasper Therapeutics, Inc

JSPRNASDAQ · Biological Products, (No Diagnostic Substances)
Write an idea

Price
FilingsNewest: 8-K, Shareholder voteOct 5 →InsidersNo open-market buys or sales.→HoldersVelan Capital 9.5%Acorn Capital 5.1%Kingdon 4.8%→Financing →PeersClosest companies: PCSA, SNTI, IMUX→

From the filings

Figures

Net income
$44.0Mlast 12 months
Operating cash flow
−$68.9Mlast 12 months
Cash and equivalents
$7.3Mat the last balance sheet
Shares outstanding
28.1M shareson issue
Every year and quarter →